This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción CLS1
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Recompensas
Análisis de riesgos
Competidores de McKesson Europe AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €24.40 |
| 52 Week High | €24.50 |
| 52 Week Low | €19.80 |
| Beta | 0.13 |
| 1 Month Change | 0.83% |
| 3 Month Change | 0.83% |
| 1 Year Change | 9.91% |
| 3 Year Change | -6.51% |
| 5 Year Change | -7.58% |
| Change since IPO | -6.51% |
Noticias y actualizaciones recientes
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01Recent updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
May 19McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital
Jan 27Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal
Sep 07McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns
Apr 29What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition
Mar 20Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?
Feb 13
Rentabilidad de los accionistas
| CLS1 | DE Healthcare | Mercado DE | |
|---|---|---|---|
| 7D | 0% | 4.1% | -1.5% |
| 1Y | 9.9% | -0.8% | 0.9% |
Rentabilidad vs. Industria: CLS1 exceeded the German Healthcare industry which returned -12.8% over the past year.
Rentabilidad vs. Mercado: CLS1 exceeded the German Market which returned 1.4% over the past year.
Volatilidad de los precios
| CLS1 volatility | |
|---|---|
| CLS1 Average Weekly Movement | 0.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: CLS1 has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: CLS1's weekly volatility (1%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
Resumen de fundamentos de McKesson Europe AG
| Estadísticas fundamentales de CLS1 | |
|---|---|
| Capitalización bursátil | €4.96b |
| Beneficios(TTM) | -€54.30m |
| Ingresos (TTM) | €9.26b |
0.5x
Ratio precio-ventas (PS)-91.3x
Ratio precio-beneficio (PE)¿Está CLS1 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CLS1 | |
|---|---|
| Ingresos | €9.26b |
| Coste de los ingresos | €8.46b |
| Beneficio bruto | €792.30m |
| Otros gastos | €846.60m |
| Beneficios | -€54.30m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.27 |
| Margen bruto | 8.56% |
| Margen de beneficio neto | -0.59% |
| Ratio deuda/patrimonio | 0.3% |
¿Cómo se ha desempeñado CLS1 a largo plazo?
Ver rendimiento histórico y comparativa